Symptoms Based Awareness Confirmation Study - CoMiSS Validation

NCT ID: NCT03004729

Last Updated: 2018-08-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-12-31

Study Completion Date

2018-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Cow's Milk-related Symptom Score (CoMiSS) tool has been developed to define a score to recognize cow's milk related symptoms in infants and young children.

Many infants and toddlers with symptoms that can be related to intake of cow's milk and cow's milk protein allergy (CMPA) are often not diagnosed due to the lack of specific markers.

The goal of this trial is to validate the CoMiSS tool in infants suspected of CMPA and investigate if the CoMiSS tool could be an alternative to the open challenge test needed to confirm the diagnosis of Cow Milk Protein Allergy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cow Milk Allergy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CoMiSS

Measure of CoMiSS followed by two weeks eviction Cow's milk protein diet and second CoMiSS measurement.

Group Type OTHER

CoMiSS questionnaire

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CoMiSS questionnaire

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female infant aged up to 6 months old
* Has been fed exclusively on cow's milk infant formula for at least one week
* Has CMPA symptoms that have been present for at least one week, and that developed within the first two months of starting cow's milk infant formula
* In the opinion of the investigator, requires a two week elimination diet with Amino Acid Formula (AAF).
* Had a gestational age at birth of 37 to 42 weeks
* Had a birthweight of 2500 g to 4500 g
* Informed consent signed by both parents, liable parent or legal guardian (if applicable).

Exclusion Criteria

* Has ever received either an extensively hydrolysed infant formula or an AAF prior to enrolment
* Has a fever above 38.5°C at enrolment
* Has ever experienced a medically diagnosed serious anaphylactic reaction
* Use of antibiotic drugs at enrolment. Infants may be enrolled if antibiotics have been stopped at least 7 days prior to enrolment. (Antibiotic treatment can be initiated during the study if an infant develops a condition after enrolment that requires antibiotic treatment).
* Infant with a health condition or family situation that makes the infant unsuitable to participate in the trial according to the opinion of the investigator
* Infant or infant's carers are unable to comply with trial procedures
* Currently participating or has participated in another clinical trial within 4 weeks prior to trial start.
Minimum Eligible Age

1 Day

Maximum Eligible Age

6 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Société des Produits Nestlé (SPN)

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zhengyan Zhao, Prof

Role: PRINCIPAL_INVESTIGATOR

The Children's Hospital Zhejiang University School of Medicine (ZUCH)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Peking University Third Hospital

Beijing, Beijing Municipality, China

Site Status

Children's Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China

Site Status

Children's Hospital of Fuzhou in Fujian province

Fuzhou, Fujian, China

Site Status

The Second Affiliated Hospital of Harbin Medical University

Harbin, Heilongjiang, China

Site Status

Children's hospital of Zhengzhou

Zhengzhou, Henan, China

Site Status

Hunan Children's Hospital

Hunan, Hunan, China

Site Status

Children's Hospital of Shanghai

Shanghai, Shanghai Municipality, China

Site Status

Children's hospital of Shanxi Women health center of Shanxi

Taiyuan, Shanxi, China

Site Status

The Children's Hospital Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

Site Status

Maternal and child health care hospital of guangdong province

Guangzhou, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Host A. Cow's milk protein allergy and intolerance in infancy. Some clinical, epidemiological and immunological aspects. Pediatr Allergy Immunol. 1994;5(5 Suppl):1-36.

Reference Type BACKGROUND
PMID: 7704117 (View on PubMed)

Sampson HA. Food allergy. Part 1: immunopathogenesis and clinical disorders. J Allergy Clin Immunol. 1999 May;103(5 Pt 1):717-28. doi: 10.1016/s0091-6749(99)70411-2.

Reference Type BACKGROUND
PMID: 10329801 (View on PubMed)

Bock SA. Prospective appraisal of complaints of adverse reactions to foods in children during the first 3 years of life. Pediatrics. 1987 May;79(5):683-8.

Reference Type BACKGROUND
PMID: 3575022 (View on PubMed)

Host A, Halken S. A prospective study of cow milk allergy in Danish infants during the first 3 years of life. Clinical course in relation to clinical and immunological type of hypersensitivity reaction. Allergy. 1990 Nov;45(8):587-96. doi: 10.1111/j.1398-9995.1990.tb00944.x.

Reference Type BACKGROUND
PMID: 2288394 (View on PubMed)

Schrander JJ, van den Bogart JP, Forget PP, Schrander-Stumpel CT, Kuijten RH, Kester AD. Cow's milk protein intolerance in infants under 1 year of age: a prospective epidemiological study. Eur J Pediatr. 1993 Aug;152(8):640-4. doi: 10.1007/BF01955238.

Reference Type BACKGROUND
PMID: 8404966 (View on PubMed)

Vandenplas Y; Althera Study Group; Steenhout P, Grathwohl D. A pilot study on the application of a symptom-based score for the diagnosis of cow's milk protein allergy. SAGE Open Med. 2014 Feb 13;2:2050312114523423. doi: 10.1177/2050312114523423. eCollection 2014.

Reference Type BACKGROUND
PMID: 26770708 (View on PubMed)

Vandenplas Y, Steenhout P, Planoudis Y, Grathwohl D; Althera Study Group. Treating cow's milk protein allergy: a double-blind randomized trial comparing two extensively hydrolysed formulas with probiotics. Acta Paediatr. 2013 Oct;102(10):990-8. doi: 10.1111/apa.12349. Epub 2013 Aug 5.

Reference Type BACKGROUND
PMID: 23837862 (View on PubMed)

Vandenplas Y, Dupont C, Eigenmann P, Host A, Kuitunen M, Ribes-Koninckx C, Shah N, Shamir R, Staiano A, Szajewska H, Von Berg A. A workshop report on the development of the Cow's Milk-related Symptom Score awareness tool for young children. Acta Paediatr. 2015 Apr;104(4):334-9. doi: 10.1111/apa.12902. Epub 2015 Jan 29.

Reference Type BACKGROUND
PMID: 25557474 (View on PubMed)

Vandenplas Y, Zhao ZY, Mukherjee R, Dupont C, Eigenmann P, Kuitunen M, Ribes Koninckx C, Szajewska H, von Berg A, Bajerova K, Meyer R, Salvatore S, Shamir R, Jarvi A, Heine RG; MOSAIC Study Investigator Group. Assessment of the Cow's Milk-related Symptom Score (CoMiSS) as a diagnostic tool for cow's milk protein allergy: a prospective, multicentre study in China (MOSAIC study). BMJ Open. 2022 Feb 17;12(2):e056641. doi: 10.1136/bmjopen-2021-056641.

Reference Type DERIVED
PMID: 35177461 (View on PubMed)

Vandenplas Y, Mukherjee R, Dupont C, Eigenmann P, Host A, Kuitunen M, Ribes-Koninkx C, Shah N, Szajewska H, von Berg A, Heine RG, Zhao ZY; on behalf the Chinese CoMiSS Investigator Team.. Protocol for the validation of sensitivity and specificity of the Cow's Milk-related Symptom Score (CoMiSS) against open food challenge in a single-blinded, prospective, multicentre trial in infants. BMJ Open. 2018 May 17;8(5):e019968. doi: 10.1136/bmjopen-2017-019968.

Reference Type DERIVED
PMID: 29773698 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

16.05.CLI

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dietary Restriction Efficiency Assessment in CMPA
NCT07199023 NOT_YET_RECRUITING NA
Milk Desensitization in Children
NCT03644381 UNKNOWN NA